P205 | THE PROGNOSTIC VALUE AND CLINICAL IMPACT OF ASXL1 MUTATIONS IN MYELOFIBROSIS: A RETROSPECTIVE COLLECTION

BACKGROUD: Next-generation sequencing (NGS) has unveiled novel non-driver mutations in myelofibrosis (MF), beyond the common driver mutations. Among these, ASXL1 gene is the most frequently involved and is considered within the high-molecular risk (HMR) group alongside EZH2, SRSF2, IDH1/2, and U2AF...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	A. Laganà, E. Rossi *, G. Iaquinta *, F. Ramundo, F. Frioni, M. Rossi, L. Maurillo, R. Latagliata, S.L. Crescenzi, A. Tamburini, K. Paciaroni, M. Santopietro, C. Tatarelli, P. Grammatico, V. De Stefano, P. Chiusolo, and M. Breccia, N/A *
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Ferrata Storti Foundation 2025-09-01
Sarja:	Haematologica
Linkit:	https://haematologica.org/article/view/12402
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!